Loading clinical trials...
Loading clinical trials...
Cell Distribution in Induced Sputum in Healthy Subjects and Patients With Asthma After Different Techniques for Sputum Induction
The aim of this case-control study is the comparison of the cell distribution in induced sputum in young adults with asthma and in healthy controls. The study consists of two visits. At both visits subjects are asked to perform a lung function test (body plethysmography) and levels of exhaled nitric oxide (eNO) are measured. At the first visit a blood sample is drawn to determine the inflammatory and allergic status of the subjects and the sputum is induced by an ultrasonic nebulizer. At the second visit another sputum sample is induced by a nozzle nebulizer. The cell distribution will be evaluated in both sputum samples.
Objectives: The aim of this study is the characterization of healthy children/ young adults and matched patients with asthma in terms of lung function, and the degree of the systemic and bronchial inflammation. Sputum and serum samples are analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and by a cytometric bead assay (CBA). Components of the innate immune system (mannose-binding protein, TLR recognition proteins and surfactant proteins) are determined from sputum or blood respectively. Methods and Work Programme: This study consists of two study visits (V1 and V2) V1 (day 0 - duration 1 hour): * Measurement of exhaled nitric oxide (eNO) * Lung function testing with and body plethysmography * Blood test: blood count, CRP, RAST, serum inflammatory mediators, markers of the non-specific pulmonary defense system * Induced sputum attained by an ultrasonic-nebulizer for inflammatory mediators and microbiological investigations V2 (day 14-28 - duration 1 hour): * Measurement of nitric oxide in expired air (eNO) * Lung function testing with spirometry and body plethysmography * Induced sputum attained by a nozzle-nebulizer for inflammatory mediators and microbiological investigations Study population: Children, adolescents and young people (6 - 25 years of age). Both the patients and the healthy subjects are recruited from the outpatient clinic of Pediatric Allergy and Pulmonology.
Age
6 - 25 years
Sex
ALL
Healthy Volunteers
Yes
Children's Hospital, Goethe-University
Frankfurt am Main, Hesse, Germany
Start Date
November 1, 2011
Primary Completion Date
May 1, 2012
Completion Date
June 1, 2012
Last Updated
July 2, 2012
40
ACTUAL participants
Lead Sponsor
Johann Wolfgang Goethe University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions